Related Experiment Video
Updated: Aug 8, 2026
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen
1Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA. Zhengrong.cui@oregonstate.edu
International Journal of Pharmaceutics
|May 30, 2006
Summary
Developing a new anthrax DNA vaccine for topical skin delivery offers a simplified immunization schedule. This approach shows potential for easier anthrax vaccination, improving upon current lengthy schedules.
Area of Science:
- Immunology
- Vaccinology
- Biotechnology
Background:
- The current anthrax vaccine adsorbed (AVA) has a complex dosing schedule, creating a need for improved alternatives.
- Developing a simplified anthrax vaccine is critical for public health preparedness.
Purpose of the Study:
- To assess the feasibility of a topical DNA vaccine for anthrax using a protective antigen (PA) DNA vaccine.
- To evaluate topical skin immunization for priming and boosting responses against anthrax.
Main Methods:
- Mice were immunized topically with a plasmid encoding PA63 (pGPA) in a perflubron-based microemulsion.
- PA-specific antibody responses and lethal toxin-neutralization activity were measured.
- Topical boosting strategies were investigated in mice primed with PA protein.
Main Results:
- Topical immunization with the PA DNA vaccine induced significant PA-specific antibody responses.
- The induced antibodies demonstrated anthrax lethal toxin-neutralization activity.
- Topical boosting enhanced anti-PA antibody responses in previously primed mice.
Conclusions:
- Topical DNA vaccination is a feasible strategy for inducing protective immune responses against anthrax.
- This novel topical anthrax DNA vaccine could simplify immunization schedules.
- Combination with existing vaccines may offer a more convenient vaccination regimen.
